Advocacy Aimed at Improving Access and Outcomes in Cancer Care: To address policies and practices that affect patient care and access, each participating oncology state society leads a policy and advocacy program focused on legislation and regulations impacting cancer care. The program has expanded its reach by collaborating with local and national organizations and state lobbyists to prioritize key legislative issues.
The policy program has helped establish a policy communication and learning infrastructure in 15 participating states with over 130 engaged multidisciplinary providers across the US, demonstrating the collective power available to drive meaningful change. By collaborating to address key policy issues, members can have a tangible impact on improving patient care and quality of life for both patients and caregivers.
To learn more about your state’s policy committee, email Lu Anne Bankert at lbankert@accc-cancer.org.
Session Overview
The 2026 North Carolina General Assembly focused on healthcare access, workforce development, and continued implementation of Medicaid expansion while considering several policies designed to improve patient access to care. Although relatively few oncology-specific bills became law during the session, lawmakers continued evaluating legislation that would directly affect cancer patients, including efforts to expand insurance coverage for biomarker testing.
One of the session’s most important oncology priorities was House Bill 567, the Ensure Access to Biomarker Testing Act. The legislation passed the House with strong bipartisan support before being referred to the Senate Rules and Operations Committee, where it remains pending. Because the bill is still eligible for consideration when lawmakers return on July 27, 2026, biomarker testing remains an active legislative issue. If enacted, the legislation would significantly expand patient access to precision medicine by requiring coverage of evidence-based biomarker testing.
North Carolina also continued advancing policies to expand the healthcare workforce and to improve patient access while reducing administrative burden. Although additional reforms remain under consideration, the 2026 session demonstrated continued interest in strengthening healthcare access and modernizing insurance regulation.
What is Pending
Why It Matters for Oncology Practices
As the General Assembly returns to session on July 27, continued advocacy from oncology stakeholders will be vital to getting House Bill 567 considered by the Senate Rules and Operations Committee. This legislation represents a critical opportunity to expand access to precision medicine for North Carolina cancer patients.
Biomarker testing has become an essential component of modern cancer care, helping oncologists identify targeted therapies, personalize treatment decisions, and improve patient outcomes. Consistent insurance coverage for evidence-based biomarker testing would help reduce financial barriers and ensure more patients have timely access to precision oncology.
The outcome of House Bill 567 will help determine whether insurance coverage keeps pace with advances in precision oncology. As the legislative process continues, the bill remains an important opportunity to strengthen access to personalized cancer care for patients across North Carolina.
Stay informed on recent federal policy changes impacting oncology care, including Medicare telehealth extensions, expanded cancer screening coverage, and increased investment in cancer research. These updates highlight important opportunities to support patient access and strengthen care delivery, underscoring the value of ongoing advocacy engagement.
Guide to Getting Started in State-Level Oncology Advocacy
Interested in shaping cancer care policy in your state but not sure where to begin? Download our resource guide created for oncology professionals looking to make an impact. Whether you're new to advocacy or looking to get more involved, this tool kit provides step-by-step instructions and resources to help you take the next step. Learn about key legislative issues going on in your state, such as prior authorization reform, PBM reform, co-pay accumulator protections, biomarker testing access, and white bagging, and more—and how they affect cancer care delivery. This guide outlines practical tips on how to connect with your state society, share your story with local legislators, track state bills, and get involved in Hill Days. Download the guide and start advocating for better cancer care today. Contact your Executive Director for more information!
2025 Policy Town Hall
In June 2025, multidisciplinary health care professionals, policy experts, and leaders from oncology state societies convened for the second annual Policy Town Hall to examine how state-level advocacy is shaping the future of cancer care within a complex policy landscape.
This year's discussion highlighted legislative progress and emerging challenges across the country. Topics included:
Engaging in advocacy through our state societies is one of the most direct ways we can have a voice in healthcare policies impacting the care of our patients.
- Haley M. Simpson, MD, PhD
Policy Committee
Innovation in Action: Breaking Down the 2025 ACCC Impact Report: Hear from ACCC Executive Director Meagan O’Neill who speaks about the 2025 ACCC Impact Report, highlighting advancements in financial advocacy, patient-centered care for Veterans with cancer, and access to cutting-edge therapies like CAR T-cell therapy.
Policy in Practice: Change Hits the Clinic: Changing regulations are reshaping the practice of oncology. Learn from 3 oncology professionals, representing different roles and regions of the country, about how their experiences with policy issues such as prior authorization, shifting coverage policies, reporting mandates, and reimbursement certainty impacts care delivery.
LIVE from AMCCBS: Leading Policy Change at the State Level: Live from ACCC 51st Annual Meeting and Cancer Business Summit (AMCCBS), hear from Dr. Wade Swenson on how engaging in advocacy positively impacts oncology.
Role of Fellows in Medical Advocacy: Discover the importance, benefits, and long-term impact of engaging in policy and advocacy starting during oncology fellowship.
Impact of Medicare Part D Changes on Access to Care: Hear about the measures providers can take to educate their patients on the impact of Medicare policy updates on cancer care.
New Payments for Patient Navigation: Live from ACCC 50th Annual Meeting and Cancer Center Business Summit (AMCCBS), Dr. Mandi Pratt-Chapman discusses new patient navigation payments.
2024 Trending Now in Cancer Care: Hear from ACCC executive director Meagan O’Neill on trends in cancer care, including AI and prior authorization.
Policy Perspectives on Biomarker Testing Coverage for 2024: Hear policy perspectives and the latest state legislation for biomarker testing for Medicaid beneficiaries.
Advancing Critical Priorities at the State Level: Louisiana, Iowa, and Washington Awarded for Their Efforts at 2026 ASCO Annual Meeting
2026-07-2915 Years Strong: The NCCN State Oncology Society Forum Annual Meeting
2026-06-16Cancer Care Tailored to Veterans and First Responders: An NCCN Patient Advocacy Summit
2025-12-22Service, Sacrifice, and Survival: Advancing Cancer Care for America’s Heroes
2025-12-18Lung Cancer Awareness Month: Addressing Inequities and Expanding Access to Care
2025-11-24The Most Favored Nation Mandate: What the President’s Drug Pricing Push Means for the Pharmaceutical Industry, Payers, and Patients
2025-10-08AI’s Changing Role in Oncology: Recapping the NCCN Summit
2025-10-03NCCN Policy Summit: Empowering and Shaping Primary Care and Oncology Partnerships
2025-06-17#AMCCBS: Advocating on Capitol Hill
2025-03-05Turning Action Into Outcomes: Highlights From the ACCC 2025 Impact Report
2025-02-03